Literature DB >> 12402260

Mitochondrial respiratory chain function in skeletal muscle of ALS patients.

Andoni Echaniz-Laguna1, Joffrey Zoll, Florence Ribera, Christine Tranchant, Jean-Marie Warter, Jean Lonsdorfer, Eliane Lampert.   

Abstract

Evidence implicating mitochondrial dysfunction in the central nervous system of patients with sporadic amyotrophic lateral sclerosis (SALS) has recently been accumulating. In contrast, data on mitochondrial function in skeletal muscle in SALS are scarce and controversial. We investigated the in situ properties of muscle mitochondria in patients with early-stage SALS and sedentary (SED) controls using the skinned fiber technique to determine whether respiration of muscle tissue is altered in early-stage SALS in comparison with SED. Musculus vastus lateralis biopsies were obtained from 7 SED group members and 14 patients with early-stage SALS (mean disease duration, 9 months). Muscle fibers were permeabilized with saponine and then skinned and placed in an oxygraphic chamber to measure basal (V(0)) and maximal (V(max)) adenosine diphosphate-stimulated respiration rates and to assess mitochondrial regulation by adenosine diphosphate. Muscle oxidative capacity, evaluated with V(max), was identical in patients in the SALS and SED groups (V(0): SALS, 1.1 +/- 0.1; SED, 0.8 +/- 0.1, micromol 0(2). min(-1). gm(-1)dw and V(max): SALS, 3.1 +/- 0.3; SED, 2.5 +/- 0.3, micromol 0(2). min(-1). gm(-1)dw). This study shows an absence of large mitochondrial damage in skeletal muscle of patients with early-stage SALS, suggesting that mitochondrial dysfunction in the earlier stages of SALS is almost certainly not systemic.

Entities:  

Mesh:

Year:  2002        PMID: 12402260     DOI: 10.1002/ana.10357

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

1.  Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice.

Authors:  Yi-Bing Zhu; Zu-Hang Sheng
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Amyotrophic lateral sclerosis and skeletal muscle: an update.

Authors:  O Pansarasa; D Rossi; A Berardinelli; C Cereda
Journal:  Mol Neurobiol       Date:  2013-11-08       Impact factor: 5.590

Review 3.  Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.

Authors:  Luc Dupuis; Andoni Echaniz-Laguna
Journal:  Curr Drug Targets       Date:  2010-10       Impact factor: 3.465

Review 4.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 5.  Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?

Authors:  Sandra R Bacman; Walter G Bradley; Carlos T Moraes
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

6.  Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status.

Authors:  Christian Lunetta; Andrea Lizio; Lucio Tremolizzo; Massimiliano Ruscica; Chiara Macchi; Nilo Riva; Patrick Weydt; Ettore Corradi; Paolo Magni; Valeria Sansone
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

7.  Evaluation of quantitative and qualitative aspects of mitochondrial function in human skeletal and cardiac muscles.

Authors:  Benoit N'Guessan; Joffrey Zoll; Florence Ribera; Elodie Ponsot; Eliane Lampert; Renée Ventura-Clapier; Vladimir Veksler; Bertrand Mettauer
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

Review 8.  The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death.

Authors:  H Muyderman; P G Hutson; D Matusica; M-L Rogers; R A Rush
Journal:  Neurochem Res       Date:  2009-04-28       Impact factor: 3.996

9.  Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.

Authors:  Aparna Sharma; Anu Mary Varghese; Kalyan Vijaylakshmi; Rajendrarao Sumitha; V K Prasanna; S Shruthi; B K Chandrasekhar Sagar; Keshava K Datta; Harsha Gowda; Atchayaram Nalini; Phalguni Anand Alladi; Rita Christopher; Talakad N Sathyaprabha; Trichur R Raju; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

Review 10.  Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?

Authors:  H Muyderman; T Chen
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.